Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Meisel

Showing results (231-240 of 236) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 236 results.
Journal of Clinical Immunology|May 5, 2022
Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodiesBengisu Akbil, Tim Meyer, Paula Stubbemann, et al.
The Lancet. Respiratory Medicine|May 9, 2021
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entityMarcin F Osuchowski, Martin S Winkler, Tomasz Skirecki, et al.
Brain : a Journal of Neurology|June 27, 2023
The spinal cord injury-induced immune deficiency syndrome: results of the SCIentinel studyMarcel A Kopp, Christian Meisel, Thomas Liebscher, et al.
Nature|October 25, 2021
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cellsMario Witkowski, Caroline Tizian, Marta Ferreira-Gomes, et al.
Cell|January 15, 2022
Complement activation induces excessive T cell cytotoxicity in severe COVID-19Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, et al.
Cell|August 19, 2020
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell CompartmentJonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, et al.
Pageof 24

Showing results (231-240 of 236) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 236 results.
Journal of Clinical Immunology|May 5, 2022
Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodiesBengisu Akbil, Tim Meyer, Paula Stubbemann, et al.
The Lancet. Respiratory Medicine|May 9, 2021
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entityMarcin F Osuchowski, Martin S Winkler, Tomasz Skirecki, et al.
Brain : a Journal of Neurology|June 27, 2023
The spinal cord injury-induced immune deficiency syndrome: results of the SCIentinel studyMarcel A Kopp, Christian Meisel, Thomas Liebscher, et al.
Nature|October 25, 2021
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cellsMario Witkowski, Caroline Tizian, Marta Ferreira-Gomes, et al.
Cell|January 15, 2022
Complement activation induces excessive T cell cytotoxicity in severe COVID-19Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, et al.
Cell|August 19, 2020
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell CompartmentJonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, et al.
Pageof 24